Dutch company of Blueprint Medicines, a US precision-therapy biopharmaceutical company, which holds European marketing authorisations and supplies its targeted medicines for systemic mastocytosis and certain cancers.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen